Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - bosentanum - compresse rivestite con film - bosentanum 125 mg ut bosentanum monohydricum 129.082 mg, maydis amylum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.315 mg, povidonum k 90, glyceroli dibehenas, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, ethylcellulosum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - primaria e secondaria di ipertensione polmonare; sclerosi sistemica attiva digitale ulzerationserkrankung - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 6.5 mg, hypromellosum, e 171, triacetinum, e 172 (flavum), acidum stearicum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 16.7 mg, hypromellosum, e 171, triacetinum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 7.6 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), e 172 (flavum), macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 4.9 mg, hypromellosum, e 171, triacetinum, e 172 (nigrum), macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - miglustatum - capsule - miglustatum 100 mg, carboxymethylamylum natricum a, povidonum k 30, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: e 172 (nigrum), lacca, pro capsula corresp. natrium 190 µg. - trattamento della malattia di gaucher di tipo 1, il trattamento neurologica progressiva manifestazioni pazienti adulti e pediatrici con niemann-pick, malattia di tipo c - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - flunarizinum - compresse - flunarizinum 5 mg ut flunarizini hydrochloridum 5.89 mg, lactosum monohydricum 57.42 mg, maydis amylum, hypromellosum, polysorbatum 20, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.21 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. - calciumantagonist, disturbi circolatori - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - paliperidonum - retardtabletten - paliperidonum 3 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum k 29-32, acidum stearicum, e 172 (rubrum), e 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, lactosum monohydricum 13.2 mg, triacetinum, cera carnauba, e 171, drucktinte: hypromellosum, propylenglycolum, e 172 (nigrum), pro compresso obducto. - antipsicotico - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - paliperidonum - retardtabletten - paliperidonum 6 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum k 29-32, acidum stearicum, e 172 (rubrum), e 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, macrogolum 400, cera carnauba, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: hypromellosum, propylenglycolum q.s., e 172 (nigrum), pro compresso obducto. - antipsicotico - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - paliperidonum - retardtabletten - paliperidonum 9 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum k 29-32, acidum stearicum, e 172 (rubrum), e 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, macrogolum 400, cera carnauba, e 171, e 172 (rubrum), drucktinte: hypromellosum, propylenglycolum, e 172 (nigrum), pro compresso obducto. - antipsicotico - synthetika